What is your regimen of choice for metastatic papillary renal cell carcinoma?

Topics: Genitourinary Cancers • Medical Oncology • Renal Cell Carcinoma

Answer from: Medical Oncologist at Academic Institution

My regimen of choice for papillary RCC is cabozantinib given recent evidence. Papillary renal cancer has not had a standard established therapy until recently. Most of the clinical trials in kidney cancer restricted eligibility to clear cell carcinoma component. SWOG 1500 reported results of a rando...

Comments

Medical Oncologist at University Medical Oncology
Thank you!! How do you feel about cabozantinib/niv...

Medical Oncologist at Dana-Farber Cancer Institute
Given the SWOG 1500 trial showing activity of cabo...

Medical Oncologist at Vanderbilt Ingram Cancer Center
Anxiously awaiting the results of the ALLIANCE A03...

Medical Oncologist at Loyola University Chicago Stritch School of Medicine
Just a quick update to @Ulka N. Vaishampayan's ter...

Medical Oncologist at NYU Langone Medical Center
In metastatic renal papillary responding to PDL1 i...

Answer from: Medical Oncologist at Community Practice

I have had a few papillary patients I have put on nivo cabo with surprisingly little fuss from insurance. Extrapolating data that each of them are individually effective in papillary. The problem I run into is what to do at progression, perhaps lenvatinib, or axitinib, or maybe even TiVo in this set...

Related Questions